Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ACC Action Center

Stopping aspirin after 1 month DAPT in ACS patients after stenting

Gregg Stone at the ACC24
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Gregg Stone, MD is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY, US. 

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Release date: 8 april 2024

Recommended
Details
Presenters
Comments
  • Overview

    ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Gregg Stone, MD is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY, US. 

  • Disclaimer

    This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

    Release date: 8 april 2024

Schedule7 Nov 2024